Overview
Anne Bourbonnais practices practicing medicine in Quebec, Canada.
Her clinical expertise encompasses Delirium, Dementia, Drug Induced Dyskinesia, and Alzheimer's Disease.
She is actively involved in clinical research, co-authoring 48 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anne Bourbonnais
Is Anne Bourbonnais a top-rated expert for Delirium?
MediFind is an objective health platform that identifies experts based on real-world data. Anne Bourbonnais is classified as an Experienced expert for Delirium, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anne Bourbonnais participate in research or clinical trials?
Yes. Anne Bourbonnais has published 48 articles and abstracts on conditions like Delirium. You can view a list of Anne Bourbonnais's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Alzheimer's DiseaseMs. Bourbonnais isExperienced. Learn about Alzheimer's Disease.
- DeliriumMs. Bourbonnais isExperienced. Learn about Delirium.
- DementiaMs. Bourbonnais isExperienced. Learn about Dementia.
- Drug Induced DyskinesiaMs. Bourbonnais isExperienced. Learn about Drug Induced Dyskinesia.